Topical tacrolimus therapy for antibiotic-refractory pouchitis

Diseases of the Colon and Rectum

Volumn 56, Issue 10, 2013, Pages 1166-1173

  Uchino, Motoi ^a   Ikeuchi, Hiroki ^a   Matsuoka, Hiroki ^a   Bando, Toshihiro ^a   Hida, Nobuyuki ^a   Nakamura, Shiro ^a   Takesue, Yoshio ^a   Tomita, Naohiro ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Enema; Pouchitis; Tacrolimus; Ulcerative colitis

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CIPROFLOXACIN; CORTICOSTEROID; INFLIXIMAB; METRONIDAZOLE; PROBIOTIC AGENT; TACROLIMUS;

ABDOMINAL CRAMP; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BIFIDOBACTERIUM BIFIDUM; BURNING SENSATION; CLOSTRIDIUM DIFFICILE; CYTOMEGALOVIRUS; CYTOPENIA; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; ENDOSCOPIC BIOPSY; FECES INCONTINENCE; FEMALE; FEVER; GLUCOSE INTOLERANCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILEITIS; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MELENA; PROCTOCOLECTOMY; RELAPSE; REMISSION; TREATMENT DURATION;

ADMINISTRATION, TOPICAL; ADULT; ANTI-BACTERIAL AGENTS; C-REACTIVE PROTEIN; COLITIS, ULCERATIVE; ENEMA; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PILOT PROJECTS; POUCHITIS; PROCTOCOLECTOMY, RESTORATIVE; SEVERITY OF ILLNESS INDEX; TACROLIMUS; TREATMENT FAILURE;

EID: 84884494852     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0b013e31829ebd83     Document Type: Article

References (22)

1. Fazio VW, Ziv Y, Church JM, et al. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg. 1995;222:120-127.
2. Penna C, Dozois R, Tremaine W, et al. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut. 1996;38:234-239. (Pubitemid 26046819)
3. Hurst RD, Molinari M, Chung TP, Rubin M, Michelassi F. Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg. 1996;131:497-501.
4. Ståhlberg D, Gullberg K, Liljeqvist L, Hellers G, Löfberg R. Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors. Dis Colon Rectum. 1996;39:1012-1018. (Pubitemid 26304984)
5. Uchino M, Ikeuchi H, Matsuoka H, Bando T, Takesue Y, Tomita N. Clinical features and management of pouchitis in Japanese ulcerative colitis patients [published online ahead of print October 18, 2012]. Surg Today. doi: 10.1007/s00595-012-0377-4.
6. Pardi DS, Sandborn WJ. Systematic review: the management of pouchitis. Aliment Pharmacol Ther. 2006;23:1087-1096. (Pubitemid 43779347)
7. Shen B. Diagnosis and treatment of patients with pouchitis. Drugs. 2003;63:453-461. (Pubitemid 36337726)
8. Calabrese C, Gionchetti P, Rizzello F, et al. Short-term treatment with infliximab in chronic refractory pouchitis and ileitis. Aliment Pharmacol Ther. 2008;27:759-764. (Pubitemid 351490077)
9. van Dieren JM, Kuipers EJ, Samsom JN, Nieuwenhuis EE, van der Woude CJ. Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: their mechanisms of action and role in the treatment of IBD. Inflamm Bowel Dis. 2006;12:311-327.
10. Baumgart DC, Wiedenmann B, Dignass AU. Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease. Aliment Pharmacol Ther. 2003;17:1273-1281. (Pubitemid 36693728)
11. Bousvaros A, Kirschner BS, Werlin SL, et al. Oral tacrolimus treatment of severe colitis in children. J Pediatr. 2000;137:794-799.
12. Fellermann K, Tanko Z, Herrlinger KR, et al. Response of refractory colitis to intravenous or oral tacrolimus (FK506). Inflamm Bowel Dis. 2002;8:317-324.
13. Högenauer C, Wenzl HH, Hinterleitner TA , Petritsch W. Effect of oral tacrolimus (FK 506) on steroid-refractory moderate/severe ulcerative colitis. Aliment Pharmacol Ther. 2003;18:415-423. (Pubitemid 37070240)
14. Ogata H, Matsui T, Nakamura M, et al. A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis. Gut. 2006;55:1255-1262. (Pubitemid 44277355)
15. Kershner RP, Fitzsimmons WE. Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation. Transplantation. 1996;62:920-926. (Pubitemid 26360352)
16. Laskow DA, Vincenti F, Neylan JF, Mendez R, Matas AJ. An openlabel, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group. Transplantation. 1996;62:900-905. (Pubitemid 26360348)
17. Heuschen UA , Allemeyer EH, Hinz U, et al. Diagnosing pouchitis: comparative validation of two scoring systems in routine follow-up. Dis Colon Rectum. 2002;45:776-786.
18. Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Phillips SF. Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc. 1994;69:409-415. (Pubitemid 24132681)
19. Fazio VW, O?Riordain MG, Lavery IC, et al. Long-term functional outcome and quality of life after stapled restorative proctocolectomy. Ann Surg. 1999;230:575-584.
20. Boguniewicz M, Fiedler VC, Raimer S, Lawrence ID, Leung DY, Hanifin JM. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group. J Allergy Clin Immunol. 1998;102(4 pt 1):637-644.
21. van Dieren JM, van Bodegraven AA, Kuipers EJ, et al. Local application of tacrolimus in distal colitis: feasible and safe.Inflamm Bowel Dis. 2009;15:193-198.
22. Hibi T, Naganuma M, Kitahora T, Kinjyo F, Shimoyama T. Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis. J Gastroenterol. 2003;38:740-746. (Pubitemid 37161337)